08 April 2026
Efferon first distributors meeting

An important milestone for Efferon and our partners: our first distributors meeting, where we brought together the majority of our partners in one place.
Despite being a young company, Efferon is already present in 40 countries across four continents. And this is just the beginning! Our progress is driven by two key factors: an exceptional team and cutting-edge hemoadsorption technology.
A key highlight of the meeting was hearing directly from our distributors. Partners shared growth stories from local markets, their participation in national congresses, and how Efferon technologies are being introduced into clinical practice. We also heard about the treatment successes in different countries. Modern ICU is can’t be imagined without hemoadsorption, and we are proud that Efferon provides physicians worldwide with an effective tool to support their patients.
Looking ahead, we are actively expanding into new markets. Our ambitions are bold, and our partners are an integral part of this journey. We move forward together, hand in hand. Because success here is always mutual!
The sky is the limit, and there is much more to come. Thank you!
More news
- Efferon®NEO Receives CE MDR Mark22 April 2026
- Efferon at ISICEM10 April 2026
- Efferon is now available in Poland11 March 2026
- Efferon®LPS is available in Costa Rica26 February 2026
- Efferon®LPS is now approved in Thailand18 February 2026
- Efferon LPS® incorporated into clinical guidelines of the German Society of Nephrology for therapeutic apheresis10 December 2025
- We’ll see each other in Greece25 November 2025
- Efferon therapies are now available in Armenia!05 November 2025
- Clinical data confirmed the effectiveness of Efferon NEO in children with sepsis30 October 2025
- Efferon LPS has been approved in the Kingdom of Saudi Arabia.18 October 2025
- Extracorporeal removal of antibiotic drugs during Efferon LPS hemoadsorption is predictable and manageable09 October 2025
- Efferon at the 6th Asia Pacific AKI CRRT Congress in Bangkok05 October 2025
- Win a New iPad! Join the Efferon LPS Photo Challenge on LinkedIn12 September 2025
- Efferon LPS hemoadsorption device has been granted regulatory approval in the United Kingdom and Croatia.23 July 2025
- Efferon LPS Now Available in Italy01 July 2025
- Applying Vicenza’s Lessons28 June 2025
- Efferon Expands Its Global Presence23 June 2025
- Efferon expands to new markets with Bertossi partnership06 June 2025
- Efferon LPS becomes available in Romania.25 May 2025
- New distribution agreements in European countries22 July 2024
- Efferon LPS receives CE mark under EU MDR29 April 2024
- Results of LASSO mRCT are published in Shock20 April 2023
- Efferon at LIVES 2022 in Paris03 November 2022
- Efferon has participated in MEDICA30 November 2021
- LASSO multicenter randomized trial launched29 April 2021